Holds 3 active US DMFs and 2 valid CEPs for methylphenidate, filing since 1997. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
EDQM certificate database
FDA, List of Drug Master Files
Holds 3 active US DMFs and 2 valid CEPs for methylphenidate, filing since 1997. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
Holds one active US DMF for methylphenidate, filing since 2016. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds one active US DMF for methylphenidate, filing since 2005. Its 2025 FDA inspection closed as NAI.
Holds one active US DMF and one valid CEP for methylphenidate, filing since 2019. Its 2025 FDA inspection closed as NAI.
Holds 2 active US DMFs for methylphenidate, filing since 2002. Its 2022 FDA inspection closed as NAI.
Holds 4 active US DMFs for methylphenidate, filing since 2010. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
Holds one active US DMF for methylphenidate, filing since 2003. Its 2025 FDA inspection closed as VAI.
Holds 2 active US DMFs for methylphenidate, filing since 2008. Its 2025 FDA inspection closed as VAI.
Holds 3 active US DMFs for methylphenidate, filing since 1993.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
This page filters the worldwide Methylphenidate manufacturer list to companies based in United States. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free